Treatment of diabetes with glucagon-like peptide-1 gene therapy

By Riedel Michael J   Kieffer Timothy J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 12, 2010-12 ,pp. : 1681-1692

Informa Healthcare

Access to resources Recommend Favorite

Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1

By Hinke S.A.   Kühn-Wache K.   Hoffmann T.   Pederson R.A.   McIntosh C.H.S.   Demuth H-U.  

Biochemical and Biophysical Research Communications, Vol. 291, Iss. 5, 2002-03 ,pp. : 1302-1308

Elsevier

Access to resources Recommend Favorite

Glucagon-like Peptide 1 Increases Glucose-Dependent Activity of the Homeoprotein IDX-1 Transactivating Domain in Pancreatic β-Cells

By Hussain M.A.   Habener J.F.  

Biochemical and Biophysical Research Communications, Vol. 274, Iss. 3, 2000-08 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

Point Mutations in the First and Third Intracellular Loops of the Glucagon-like Peptide-1 Receptor Alter Intracellular Signaling

By Heller R.S.   Kieffer T.J.   Habener J.F.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 3, 1996-06 ,pp. : 624-632

Elsevier

Access to resources Recommend Favorite

Glucagon-Like Peptide 2 (GLP-2), An Intestinotrophic Mediator

By  

Current Protein and Peptide Science, Vol. 5, Iss. 1, 2004-02 ,pp. : 51-65

Bentham Science Publishers

Access to resources Recommend Favorite